Next Article in Journal
Evaluation of Antibody Tests for Mycobacterium bovis Infection in Pigs and Deer
Previous Article in Journal
Characterization of Extended Spectrum Cephalosporin-Resistant Escherichia coli Strains Isolated from Raw Poultry Carcasses in Catering Services in Northern Greece
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

A Newly Emerging Serotype A Strain in Foot-and-Mouth Disease Virus with Higher Severity and Mortality in Buffalo than in Cattle Calves in North Egypt

1
Division of Infectious Disease, Department of Animal Medicine, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, Egypt
2
Laboratory of Global Infectious Diseases Control Science, Graduate School of Agricultural and Life Sciences, The University of Tokyo, Bunkyo-Ku, Tokyo 113-8657, Japan
3
Division of Internal Medicine, Department of Animal Medicine, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, Egypt
4
Biology Department, College of Science and Arts, King Khalid University, Muhayl Asser 61913, Saudi Arabia
5
Biology Department, Faculty of Science, Princess Nourah Bint Abdulrahman University, Riyadh 11671, Saudi Arabia
6
Department of Pharmacology and Therapeutics, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, Egypt
7
Division of Clinical Pathology, Department of Pathology, Faculty of Veterinary Medicine, Damanhour University, Damanhour 22511, Egypt
*
Authors to whom correspondence should be addressed.
Vet. Sci. 2023, 10(8), 488; https://doi.org/10.3390/vetsci10080488
Submission received: 14 June 2023 / Revised: 20 July 2023 / Accepted: 24 July 2023 / Published: 27 July 2023
(This article belongs to the Section Veterinary Microbiology, Parasitology and Immunology)

Abstract

:

Simple Summary

Foot-and-mouth disease virus (FMDV) is the etiologic agent of foot-and-mouth disease (FMD), which causes severe economic losses among cloven-hoofed animals in endemic nations. Egypt is a bridge for FMDV pools between continents, where three serotypes (A, O, and SAT2) have established an enzootic state. Recently, a severe FMD epidemic struck several farms in the Beheira province, north Egypt. This study was the first to detect the newly emerging FMDV, serotype A, Europe–South America (Euro–SA) topotype that was collected during such outbreaks in twenty calves’ tongue epithelial samples from five infected farms based on virus isolation, molecular methods, and phylogenetic analysis. Additionally, we found that this strain caused higher peracute mortalities in water buffalo (Bubalus bubalis) (25.7%; 95% CI: 13–43) than in cattle (8.6%; 95% CI: 2–24) calves. Meanwhile, in fatal cases, severe clinical signs such as dullness, hypothermia, bradycardia, and cardiac arrhythmia were common in both species. In conclusion, we first characterized the newly emerging FMDV in the calves of Beheira as more fatal and severe in buffalo than in cattle calves.

Abstract

A severe foot-and-mouth disease (FMD) epidemic struck several Egyptian provinces recently, causing significant losses among animals even in vaccinated farms. This study indicated the existence of the newly emerging foot-and-mouth disease virus (FMDV) and first investigated its effect on the Egyptian water buffalo (Bubalus bubalis) and cattle calves in the Beheira province, north Egypt. Twenty tongue epithelial samples from diseased calves in five infected farms were randomly collected, prepared, and propagated using baby hamster kidney-21 (BHK-21) cells. Whole genomic RNA was extracted from the cells of the third passage. A FMDV genome was detected and serotyped using one-step reverse transcription polymerase chain reactions (RT-PCRs). Nucleotide sequencing of the purified serotype-specific PCR bands was performed, and a maximum likelihood phylogenetic tree based on 600 base pairs of VP1 was constructed. The results identified FMDV, serotype A in all infected samples, whereas the serotypes O and SAT2 were negative. The obtained 20 sequences were identical to each other and similar to the newly reported strain in Egypt that belongs to the Europe–South America (Euro–SA) topotype. The epidemiological and clinical parameters associated with such a strain were fully recorded by veterinarians and analyzed in a single infected farm including 70 cattle and buffalo calves. It caused higher peracute mortalities in buffalo (25.7%; 95% CI: 13–43) than in cattle (8.6%; 95% CI: 2–24) calves. Severe clinical signs such as dullness, hypothermia, bradycardia, and cardiac arrhythmia were common to both except in fatal cases, whereas hyperthermia and respiratory signs were prevalent in cattle calves. In conclusion, we first characterized the newly emerging FMDV in the calves of Beheira as more fatal and severe in buffalo than in cattle calves.

1. Introduction

Foot-and-mouth disease (FMD) is a highly contagious disease in domestic, cloven-hoofed animals including cattle, buffaloes, goats, sheep, pigs, and more than 70 wild animal species [1,2]. It is caused by the foot-and-mouth disease virus (FMDV), a small, non-enveloped, single-stranded RNA virus belonging to the Aphthovirus genus of the family Picornaviridae [3]. FMD is regarded as the main cause of economic loss in the dairy and beef industries in endemic nations, as well as the main obstacle to international trade in animals and animal products [4,5,6]. It is characterized clinically by fever and vesicle formation on the mouth, muzzle, teats, and feet, which causes ropy salivation, difficult mastication, and lameness. Morbidity in a population at risk was close to 100%, and young animals have significant mortality rates [4,7,8]. In calves, myocarditis is considered a fatal form of FMD that may occur without developing the characteristic vesicular lesions [8,9,10].
Seven immunologically different serotypes of FMDV, namely A, O, C, Asia 1, SAT 1, SAT 2, and SAT 3 exist, which are subdivided into a diverse number of topotypes, lineages, and sublineages [11,12,13,14]. The FMDV particle is icosahedral in shape, with a genome that is approximately 8400 nucleotides long and surrounded by a capsid protein coat [15]. The viral genome is divided into P1, P2, and P3 regions. The P1 region encodes the structural proteins, 1D (VP1), 1B (VP2), 1C (VP3), and 1A (VP4) [15], while the P2 and P3 regions encode non-structural proteins, protease, and polymerase [16]. Viral protein 1 (VP1) is responsible for virus attachment and entry, and protective immunity. It is highly polymorphic, and its nucleotide sequence is considered a golden standard for FMDV serotyping [15,17].
Globally, FMDV endemic regions have been classified into seven geographical pools [12,18,19]. In Egypt, three FMDV serotypes (A, O, and SAT2) have established an enzootic state [8,13,14,20,21]. FMDV, Serotype O was first reported in 1951 and serotype A was detected in 1972 [22]. Thirteen successive outbreaks of FMDV serotypes O and A were recorded between 1958 and 2000 [8,22]. Thirty-four FMD, serotype A outbreaks have been reported in eight Egyptian provinces in 2006 with a high genetic similarity to East African FMDV strains [23]. In 2012, infection with the newly emerged FMD, serotype SAT2 caused massive losses in cattle and buffaloes in several provinces [24]. Then, the emergence of FMDV, serotype SAT2, Lib-12 lineage of topotype VII caused an outbreak in 2018 [25]. A recent study in 2022 detected FMDV, serotype O, the Europe–South America topotype [13]. Additionally, FMDV, serotype A, the Europe–South America topotype, was detected [14].
The Egyptian FMD control program relies on mass vaccination of susceptible animals using multivalent vaccines [26]. Therefore, routine detection of the circulating serotypes is necessary [2,12,26]. Diagnosis of FMDV depends on cell-based methods, detection of specific antibodies, and molecular-based approaches using PCR and nucleotide sequencing [2,14,15,27].
Since the beginning of 2022 through the time of this analysis in May 2022, several FMD outbreaks have been observed in various provinces in Egypt. However, there was a lack of scientific research to identify the circulating serotypes. In July 2022, FMDV, serotype A, Euro-SA lineage had been first reported in a regular survey in Egypt [14]. However, the origin of this strain, how it was introduced, and its spread and virulence among Egyptian animals were poorly investigated. Therefore, this study was conducted to detect whether this strain was the causative agent during such outbreaks in the Beheira province. Additionally, we aimed to monitor the epidemiological patterns and the clinical findings associated with the circulating serotype in young buffalo (Bubalus bubalis) and cattle calves in a single infected herd based on the data recorded by the veterinarians and the farm’s records.

2. Materials and Methods

2.1. Ethical Approval

This research has obtained the approval of the Ethics of the Institutional Committee of the Faculty of Veterinary Medicine, Damanhour University, Egypt (DMU/VetINF-2022-/0148).

2.2. Study Population and Clinical Findings

At the beginning of May 2022, several cattle and buffalo farms in the Beheira province suffered from outbreaks of FMD. Therefore, we randomly collected 20 tongue epithelial samples from 20 (10 cattle and 10 buffalo) infected calves in five infected non-vaccinated farms. These farms include both cattle and water buffalo (Bubalus bubalis) calves with ages of less than one year distributed in four districts in the Beheira province, namely, Damanhour, Abu Hommus, Abu Almatamer, and Kafr El-Dawar (Table 1). Regarding the study of clinical and epidemiological parameters associated with FMDV infection, calves from an infected farm in the Abu Almatamer district were fully investigated by veterinarians. In detail, a mixed semi-intensive farm comprised of 70 female animals at 4–6 months of age (35 buffalo and 35 cattle) showed a sudden appearance of clinical symptoms of FMD among the calves. Noticeably, these animals were purchased from the animal markets of Beheira, three months before the onset of clinical symptoms without a history of previous vaccination against FMD. During the outbreak, all calves suffered from high fever, salivation, lameness, vesicular eruption, ulcers on the tongue, gum, and coronets with different degrees of severity (Figure 1), and mortalities in both species. The clinical status and parameters of calves were observed by the veterinarians during the outbreak and for two months after the disappearance of the clinical symptoms. Noticeably, all data and clinical signs shown in this study were obtained from the veterinarians, owners, and the farm’s records.

2.3. Virus Sampling and Preparation

According to the standard measurements of the World Organization of Animal Health (WOAH) [28], 20 sloughed tongue epithelium samples were randomly collected from 20 infected animals (10 buffalo and 10 cattle). The specimens were mixed with equal amounts of glycerin in 0.04 M of phosphate buffer pH 7.2 [29] and transported into the BSL-2 laboratory (Veterinary Serum and Vaccine Research Institute, Cairo, Egypt). Each specimen was homogenized manually in Eagle’s minimum essential medium (MEM) (Sigma-Aldrich, New York, NY USA, followed by centrifugation at 2000× g for 20 min, then filtrated using syringe filters (0.2 µm). The supernatants were mixed with an antibiotic mixture of 1% (100 IU/mL of Penicillin and 100 mg/mL of Streptomycin). A part of each sample was subjected to a virus propagation experiment, and the other part was stored at −80 °C.

2.4. Virus Propagation and Cytopathic Effect Monitoring

The baby hamster kidney-21 cell lines (BHK-21 Clone 13, adapted in VSVRI, Cairo, Egypt) were used for virus propagation and CPE monitoring as previously described [14]. Three successive passages with daily monitoring of the CPE were carried out. Furthermore, a culture flask containing BHK-21cells was used as a negative control without sample inoculation.

2.5. Whole Genomic RNA Extraction and Molecular FMDV Genomic Detection

The infected BHK-21 cells of the third passage were harvested. BHK-21 cells were lysed via three successive freezing and thawing cycles and centrifuged at 1200× g for 20 min, then the supernatant was filtrated using syringe filters (0.2 µm). Whole genomic RNA was extracted using the EasyPure viral-RNA kit (TransGen Biotech, Beijing, China) according to manufacturer instructions. FMDV genomic RNA was investigated in the extracted RNA samples via RT-PCR using the pan-FMDV primers/probe set as described [30]. The RNA reverse transcription step was included in the amplification cycle (45 °C for 25 min) according to the manufacturer instructions of the TransScript® Probe one-step qRT-PCR SuperMix (TransGen, Beijing, China). The PCR thermal cycle was performed on a BAX Q7 cycler (BAX Q7 systems, Marsiling, Singapore) as described previously [14].

2.6. FMDV Serotyping Using A-, O-, and SAT2-Specific Primers Targeting the 1D Gene

One-step RT-PCR was used to detect the existing FMDV serotype in the extracted RNA using serotype-specific PCR amplification of the VP1 protein genomic region. The used primer sets were amplifying 814, 1124, and 666 bp of the 1D variable gene of serotypes A, O, and SAT2, respectively, as described previously [21]. The reaction was carried out using the EasyScript® one-step RT-PCR SuperMix (TransGen, Beijing, China) according to manufacturer instructions. The thermal conditions were adjusted as described previously [14]. The PCR products were documented via UV rays after electrophoresis on 1.2% agarose gel in a Tris-acetate EDTA buffer stained with ethidium bromide for 45 min [8].

2.7. Nucleotide Sequencing, Alignment, and Phylogenetic Analysis

The VP1-amplified PCR bands (814 bp) were purified from the agarose gel using a gel purification kit (Qiagen, MD, USA) and sequenced in an ABI3730xl Genetic Analyzer (Applied Biosystems, Foster City, CA, USA) using an ABI PRISM Big Dye Terminator v 3.1 Ready Reaction Cycle Sequencing Kit (Thermo Fisher, Franklin, MA, USA). The same forward and reverse specific primers for the previous PCR were used. The obtained sequences in both directions (forward and reverse) were checked together, and multiple nucleotides and deduced amino acid sequences of the isolates were aligned together using the MEGA11 software [31]. A maximum likelihood (ML) phylogenetic tree was constructed using the Tamura 3-parameter model by MEGA11 software [31,32]. This tree was based on the 600 bp sequence of VP1, corresponding to the nucleotide positions 2364–2964 in the whole genome sequence of the KP940474/A/Egypt/2014 reference strain. It included two isolates out of the obtained identical FMDV sequences, together with the 30 sequences from the NCBI nucleotide blast (https://blast.ncbi.nlm.nih.gov/Blast.cgi (accessed on 1 July 2022)) that was reported previously in Egypt and worldwide.

2.8. Statistical Analysis

The morbidity and mortality rates were calculated via counting. An online statistics software http://vassarstats.net/ (accessed on 10 October 2022) was used to estimate the 95% confidence interval (CI) and Fisher Exact Probability Test’s (two-tailed) significance on the differences between the tested buffalo and cattle calves. A p value of <0.05 was considered statistically significant.

3. Results

3.1. Propagation of FMDV and Characterization of the CPE on BHK-21 Cells

FMDV propagation was demonstrated daily for the CPE on BHK-21 cells for three days and for three successive passages. BHK-21 cells in all inoculated flasks with the 20 supernatants from the infected calves were rounded in shape, sloughed, and died after the first day of inoculation in all passages, compared to spindle and attached confluent cells without remarkable changes in the negative control flask.

3.2. Molecular Detection and Serotyping of FMDV

FMDV was detected in all 20 RNA samples of inoculated third passages with tongue epithelium from the 20 infected calves. The positive results were indicated via the amplification of 328 bp from the 3D segment of the viral genome. For FMDV serotyping, the 20 positive samples were tested using serotype-specific primer sets which amplified 814, 1124, and 666 bp of the 1D variable gene of serotypes A, O, and SAT2, respectively. All 20 samples were positive for serotype A and negative for serotypes O and SAT2.

3.3. Nucleotide Sequences of FMDV, Serotype A

The serotype A amplicons were purified and sequenced on both sides (forward and reverse) using the same primers as the serotyping RT-PCR. The obtained sequences were edited and 600 nucleotides of the VP1 region were aligned together. The result revealed that the nucleotides and amino acid sequences of the 20 obtained isolates were identical for the VP1 region. Therefore, out of them, four identical isolates were deposited in the GenBank (https://www.ncbi.nlm.nih.gov/ (accessed on 10 November 2022)), with the accession numbers OP823161 (https://www.ncbi.nlm.nih.gov/nuccore/OP823161 (accessed on 27 November 2022)) and OP823162 for buffalo calves’ isolates, and OP823163 and OP823164 for cattle calves’ isolates.

3.4. Phylogenetic Analysis

A phylogenetic tree was constructed and included two of the obtained sequences and 30 sequences of serotype A that resulted from the nucleotide blast of NCBI. The constructed ML phylogenetic tree placed the virus within the Euro–SA topotype (Figure 2). The obtained isolates (accession No. OP823161-OP823164) were identical and shared 100% identity to the Euro–SA lineage (accession No. OP093730 and OP131711) that were reported recently by the Animal Health Research Institute, Egypt in 2022. The obtained isolates were closely related to the isolates from Venezuela (accession No. KX150534, KX150532, and KX150522) and shared 87.5%, 86.9, and 86.4% identity, respectively (Table 2). The obtained isolates shared the lowest nucleotide similarities with the previously reported serotype A, African topotype isolates from Egypt such as MH053305, MT86368, MW413351, MW413350, KP940474, KY825726, and KC440881 (Table 2). They also shared 66.8%, 66%, 65.3%, and 64.6% similarity with serotype A, Asian topotype isolates from Pakistan, Iran, India, and Vietnam, respectively (Table 2).

3.5. Amino Acid Sequences of the Immunogenic (G-H) Loop of the VP1 Region in the Obtained Strain Compared to FMD Vaccinal Strains Used in Egypt

The amino acid substitutions in the immunogenic (G-H) loop of the VP1 region in the obtained isolate (accession No. OP823161) were compared to the Euro–SA isolates from Egypt (accession No. OP093730) and Venezuela (accession No. KX150534, KX150532, and KX150522), whereas 0, 3, 3, and 2 amino acid substitutions were shown, respectively (Figure 3). More substitutions have been detected in Egyptian isolates (accession No. MW413351, MW413350, MT863268, MH053305, KY825726, KP940474, and KC440881) and revealed 4, 5, 5, 5, 7, 7, and 7 amino acid substitutions, respectively (Figure 3). The Asian, Iran05 isolate (accession No. MT981292) showed 5 amino acid substitutions (Figure 3).

3.6. The Epidemiological Patterns and Clinical Findings Related to the FMD Outbreak in One Infected Farm

Epidemiologically, all 70 calves (35 buffalo and 35 cattle) in the infected farm showed clinical signs of the disease with a morbidity rate of 100%. In total, 12 (17.1%) calves died. However, the mortality rates were 25.7% (9/35; 95% CI: 13–43) and 8.6% (3/35; 95% CI: 2–24; p = 0.11) in buffalo and cattle calves, respectively (Table 3). As reported by the veterinarians, death has been reported in a peracute form in buffalo calves (within 2–3 days), meanwhile, it took a longer time in cattle calves (6–8 days); whereas the course of the disease in recovered cases was 2–3 weeks in buffalo calves and 2–4 weeks in cattle calves (Table 3).
Clinically, the infected calves showed a wide range of signs. A full 100% of buffalo calves and over 77.1% (p = 0.004) of cattle calves experienced loss of appetite or anorexia. Buffalo calves more frequently exhibited dullness (85.7; 95% CI: 69–95) than cattle calves (62.9%; 95% CI: 45–78; p = 0.054), while the greatest difference was in observed recumbence or preferred recumbence which affected 71.4% (95% CI: 53–85) of buffalo calves but only 25.7% (95% CI: 13–43; p = 0.0002) of cattle calves (Table 3). The prominent FMD signs, such as vesicles on the mouth and foot, salivation, and lameness, have been reported in 65.7% (95% CI: 51–84), 40% (95% CI: 24–58), and 25.7% (95% CI: 13–43) of buffalo, compared to 88.6% (95% CI: 72–96; p = 0.04), 71.4% (95% CI: 53–85; p = 0.01), and 34.3% (95% CI: 20–52; p = 0.6) of cattle calves, respectively (Table 3). In total, 70 (100%) calves suffered from abnormal rectal body temperatures of 36.2–41.5 °C and 36.5–41.7 °C for buffalo and cattle calves, respectively. Hyperthermia was recorded in 65.7% (95% CI: 51–84) and 88.6% (95% CI: 72–96; p = 0.04), whereas hypothermia was recorded in 34.3% (95% CI: 20–52) and 11.4% (95% CI: 4–28; p = 0.04) of infected buffalo and cattle calves, respectively (Table 3).
Heart rates were counted via stethoscope in diseased calves (38–160 and 39–155 beats per min) of buffalo and cattle calves, respectively. Tachycardia, bradycardia, and cardiac arrhythmia were reported in 65.7% (95% CI: 51–84), 34.3% (95% CI: 20–52), and 40% (95% CI: 24–58) of buffalo, compared to 88.6% (95% CI: 72–96; p = 0.04), 11.4% (95% CI: 4–28; p = 0.04), and 17.1% (95% CI: 7–34; p = 0.06) of cattle calves, respectively (Table 3). Respiratory cycles per minute were counted for each calf (11–62 and 12–66) of buffalo and cattle, respectively. Abnormal lung sounds and nasal discharges were found in 45.7% (95% CI: 29–63) and 22.9% (95% CI: 11–41) of buffalo calves, respectively, compared to 80% (95% CI: 63–91; p = 0.005) and 57.1% (95% CI: 40–73; p = 0.006) of cattle calves, respectively (Table 3). Some chronic clinical signs that were not reported prior to the FMD outbreak have occurred. For example, out of the 58 recovered calves, 2 (7.7%; 95% CI: 1–26) buffalo calves compared to 4 (12.5%; 95% CI: 4–30; p = 0.6) cattle calves showed chronic respiratory signs, and only 2 (7.7%; 95% CI: 1–26; p = 0.19) buffalo calves suffered from chronic diarrhea (Table 3).

4. Discussion

Egypt has a bovine population of about 5.1 million heads [33], with the highest density located in the Beheira province [34]. This study proved the existence of the recently identified [14] and newly emerging FMDV, serotype A, Euro–SA in the calves of Beheira. Furthermore, it was the first to investigate the effects of this strain on the Egyptian buffalo and cattle calves, as summarized in Table 4.
In the last few years, several studies have investigated the circulating FMDV serotypes in different localities of Egypt [8,9,13,14,20,21,35,36,37,38,39]. However, since the detection of the SAT2 serotype in 2018 [21], the circulating serotypes in Beheira have never been investigated. This study indicated the circulation of the newly emerging serotype A, Euro–SA lineage in all infected farms under investigation. This strain had been first identified in Egypt in 2022 [14]. The evolution analysis of the obtained isolates revealed a close genetic relatedness to the Venezuelan isolates. There is a long history of using virus genetic data to study the international spread of FMDV [40]. In accordance with our study, the majority of studies regarding FMDV genomics are limited to VP1, as it contains serotype-specific amino acid sequences differentiating various serotypes, topotypes, and lineages [3,41,42,43,44]. In contrast, other researchers were unable to use this method to differentiate between the subtypes as there were no substitutions in VP1 sequences at the time [8].
Globalization of the FMDV spread between countries is associated with the movements of people, goods, animals, and their products. Unrestricted and illegal movements of animals are especially risky [45]. As Egypt imports live animals from several countries [34], Egypt act as a bridge for FMDV transmission between countries [12].
FMDV in South America circulates serotype A, topotype Euro–SA and serotype O, topotype Euro–SA as sporadic outbreaks in Venezuela, Colombia, and Ecuador [12,46,47]. Although the South American nations established a plan (2011–2020) for the eradication of FMD through mass vaccination of animals via 700 million doses administered annually [48], Colombia had reported the occurrence of FMD outbreaks near the borders of Venezuela in 2017 and 2018 [49]. Then, Colombia successfully eradicated such infections and regained its freedom status [14]. Surprisingly, Egypt had reported two new emerging outbreaks in 2022 related to the South American isolates [13,14]. This endorses that animal movement across international borders predisposes Egypt to newly emerging FMDV serotypes [50]. Furthermore, the genetic and antigenic relatedness of commercially used inactivated FMDV vaccinal strains and the Egyptian-circulating viruses are unknown. Therefore, huge economic losses are associated with newly emerging FMDV strains [20,26].
In this context, we compared the amino acids sequences of the immunogenic site G-H loop (residues 141–160) of VP1 [51,52] in the obtained serotype A isolates from Egypt, Venezuela, and Asia. Some of these isolates were included in the vaccines produced by the Veterinary Serum and Vaccine Research Institute in Egypt. The results suggested that routine identification of the circulating viruses in order to control the disease via vaccination is necessary [53]. Up to 2021, Egypt was using an inactivated local trivalent vaccine (containing O Pan-Asia 2, A Iran/05, and SAT2 Ghb-12 lineage seeds) in combination with a monovalent vaccine containing SAT2 Lib-12 lineage seeds for the mass vaccination of susceptible animals. Alternatively, some farmers were using an imported hexavalent vaccine (containing O Manisa, O-3039, A Iran 05, A Saudi 95, SAT2 Eritrea, and Asia1 Shamir seeds) [20]. Since July 2022, a new polyvalent FMD inactivated vaccine has been produced by VSVRI and contains O, A Iran05, A Africa 2020, SAT2-2012, A Africa G IV Egypt 2022, and A-Venezuela (http://vsvri.com/Products.html (accessed on 20 December 2022)).
In the current study, we compared the epidemiological features and clinical parameters related to such FMDV strains in buffalo and cattle calves (4–6 months old). On the semi-intensive farm level, all buffalo and cattle calves were infected. However, the mortality rate was significantly higher (25.7%) and in peracute form (within 2–3 days) in buffaloes compared to cattle calves (8.6% died within 6–8 days). These findings were in accordance with the theory that the FMDV spread in a susceptible population approaches 100% with high mortalities in young animals [4,7,8]. For example, Mahmoud and Neamat-allah [54] reported 100% mortality among infected suckling buffalo calves from Sharquia with a tiger heart appearance caused by serotype SAT2. On the other side, Hefnawy and colleagues reported a lower virulence in vaccinated buffalo calves in the Menofia province associated with serotype O infection [9]. Regarding cattle calves, the infected cattle calves in the current study showed a lower mortality rate than that caused by the previous FMDV serotypes of A and O [8]. However, Abd El Moneim and colleagues reported 93.7% of mortalities in suckling cattle calves in Dakahlia were caused by serotype A [55]. The previous studies in Egypt linked the mortalities among buffalo and cattle calves to myocarditis [8,9,38,54].
In young calves, myocarditis is the main cause of death during FMD outbreaks that may occur without the appearance of the characteristic vesicular lesions [1,9]. Our results revealed that the high and rapid fatal cases in buffalo calves were associated with hypothermia, bradycardia, and cardiac arrhythmia. However, a higher number of recovered cases in cattle calves was associated with tachycardia and rhythmic heartbeats. Furthermore, abnormal lung sounds, nasal discharges, and respiratory signs have been reported in cattle calves at a higher rate than buffalo calves, even in the chronic cases that recovered from FMD symptoms. Theoretically, FMD signs can appear within 2 to 3 days after exposure and can last for 7 to 10 days. A number of studies have suggested that the lung or pharyngeal areas are the sites of initial virus replication in cattle, with the rapid dissemination of the virus to oral and pedal epithelial areas [15]. Moreover, pneumonia and pulmonary lesions usually follow systemic infection and thrombosis of the lung after FMD infection [55]. Additionally, cattle can develop a rapid and vigorous genuine local immune response throughout the respiratory tract after/with FMD infection [56]. Notably, more than 50% of cattle that recover from FMD can become carriers with low levels of infectious virus in their pharyngeal region for a long period of time. In this case, the possibility of transmission of the disease from carrier cattle to naïve animals under controlled conditions is limited [57].
This study had two limitations. Firstly, it was carried out with a small number of samples from only five infected farms. Secondly, epidemiology and clinical findings related to such a newly emerging variant were carried out on a single infected farm. Consequently, this might broaden the CI range in mortality measurements that are used to compare cattle and buffaloes. However, as all animals used were kept on the same farm and were subjected to the same breeding, nutritional, and management conditions, the confounding effects of these factors on the disease outcome are highly reduced; therefore, we believe that the observed differences between the cattle and buffaloes are the direct result of FMDV infection. We believe that a comprehensive study including a higher number of farms could shed more light on the disease’s epidemiology and clinical picture in calves.

5. Conclusions

This study molecularly detected FMDV, serotype A, Euro-SA lineage in outbreaks in different localities of the Beheira province, where it has never been previously reported. This strain was newly emerging in Egypt, as published by the Animal Health Research Institute in July 2022. We showed a high polymorphism in the amino acid sequences of the immunogenic region (G-H loop) compared to the vaccinal strains used in Egypt. High morbidity was reported among young calves with higher peracute mortalities and more severe clinical findings in buffalo than in cattle calves. Further study is in progress to investigate the causes of higher mortality rates in buffalo than in cattle calves observed with this newly emerging FMDV variant. Additionally, a large-scale and continuous detection of FMDV variants circulating in the Beheira province is needed and the use of regularly updated vaccines is recommended.

Author Contributions

Conceptualization and design, S.M., N.B. and R.H.; experiments, formal analysis, investigation, S.M., B.F., R.H., B.E. and Y.B.; resources and shared materials, S.M., S.K.A., L.A.A.-S. and G.B.; writing—original draft, S.M., R.H. and G.B.; writing—review and editing, S.M., S.K.A., L.A.A.-S. and R.H. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

Ethical approval for this study was obtained from the Institutional Committee of Ethics in the Faculty of Veterinary Medicine, Damanhour University, Egypt (No. DMU/VetINF-2022-/0148).

Informed Consent Statement

Informed consent was obtained from the animals’ owners for voluntary participation in the study. All methods for the study were carried out in accordance with the relevant guidelines and regulations. All methods are reported in accordance with the ARRIVE guidelines (https://arriveguidelines.org (accessed on 1 May 2022)) for the reporting of animal experiments.

Data Availability Statement

The nucleotide sequence data used in this study are available on GenBank, National Library of Medicine, (NCBI) under accession numbers OP823161, OP823162, OP823163, and OP823164.

Acknowledgments

This research was funded by Princess Nourah bint Abdulrahman University Researchers Supporting Project under number (PNURSP2023R365), Princess Nourah bint Abdulrahman University, Riyadh, Saudi Arabia. The authors extend their appreciation to the Deanship of Scientific Research at King Khalid University for funding this work through Large Groups Project under grant number (R.G.P.2/77/44). We would like to acknowledge the veterinarians in the investigated farms for helping in the collection of samples as well as the owners of the animals for providing the animals’ data. We are greatly thankful to Ehab Elsayed at the Veterinary Serum and Vaccine Research Institute for helping in the virus identification for some samples.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Alexandersen, S.; Zhang, Z.; Donaldson, A.I.; Garland, A.J.M. The pathogenesis and diagnosis of foot-and-mouth disease. J. Comp. Pathol. 2003, 129, 1–36. [Google Scholar] [CrossRef]
  2. Jamal, S.M.; Belsham, G.J. Foot-and-mouth disease: Past, present and future. Vet. Res. 2013, 44, 116. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  3. Knowles, N.J.; Samuel, A.R. Molecular epidemiology of foot-and-mouth disease virus. Virus Res. 2003, 91, 65–80. [Google Scholar] [CrossRef] [PubMed]
  4. Barasa, M.; Catley, A.; Machuchu, D.; Laqua, H.; Puot, E.; Tap Kot, D.; Ikiror, D. Foot-and-Mouth Disease Vaccination in South Sudan: Benefit–Cost Analysis and Livelihoods Impact. Transbound. Emerg. Dis. 2008, 55, 339–351. [Google Scholar] [CrossRef]
  5. Knight-Jones, T.J.D.; Rushton, J. The economic impacts of foot and mouth disease–What are they, how big are they and where do they occur? Prev. Vet. Med. 2013, 112, 161–173. [Google Scholar] [CrossRef] [Green Version]
  6. Nampanya, S.; Khounsy, S.; Abila, R.; Young, J.R.; Bush, R.D.; Windsor, P.A. Financial impacts of foot-and-mouth disease at village and national levels in Lao PDR. Transbound. Emerg. Dis. 2016, 63, e403–e411. [Google Scholar] [CrossRef]
  7. Rufael, T.; Catley, A.; Bogale, A.; Sahle, M.; Shiferaw, Y. Foot and mouth disease in the Borana pastoral system, southern Ethiopia and implications for livelihoods and international trade. Trop. Anim. Health Prod. 2008, 40, 29–38. [Google Scholar] [CrossRef]
  8. Sobhy, N.M.; Bayoumi, Y.H.; Mor, S.K.; El-Zahar, H.I.; Goyal, S.M. Outbreaks of foot and mouth disease in Egypt: Molecular epidemiology, evolution and cardiac biomarkers prognostic significance. Int. J. Vet. Sci. Med. 2018, 6, 22–30. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Hefnawy, A.; Helal, M.; Marawan, M.; Abo-sakaya, R.; El Bahgy, H. Molecular study of FMD infected Egyptian buffalo calves with reference to electrocardiography and cardiac biomarkers as prognostic tools. Assiut Vet. Med. J. 2018, 64, 134–143. [Google Scholar]
  10. Aktas, M.S.; Ozkanlar, Y.; Oruc, E.; Sozdutmaz, I.; Kirbas, A. Myocarditis associated with foot-and-mouth disease in suckling calves. Vet. Arh. 2015, 85, 273–282. [Google Scholar]
  11. Mohapatra, J.K.; Subramaniam, S.; Pandey, L.K.; Pawar, S.S.; De, A.; Das, B.; Sanyal, A.; Pattnaik, B. Phylogenetic structure of serotype A foot-and-mouth disease virus: Global diversity and the Indian perspective. J. Gen. Virol. 2011, 92, 873–879. [Google Scholar] [CrossRef]
  12. Brito, B.P.; Rodriguez, L.L.; Hammond, J.M.; Pinto, J.; Perez, A.M. Review of the global distribution of foot-and-mouth disease virus from 2007 to 2014. Transbound. Emerg. Dis. 2017, 64, 316–332. [Google Scholar] [CrossRef] [PubMed]
  13. Soltan, M.A.; Abd-Eldiam, M.M.; Mahmoud, M.M.; Hegazy, Y.; Amal, A.M.; Shafek, N.G. Emergence of Foot and mouth disease virus, serotype O, Europe-South America topotype in Egypt, 2022. Transbound. Emerg. Dis 2022, 69, 2409–2411. [Google Scholar] [CrossRef] [PubMed]
  14. Hagag, N.M.; Hassan, A.M.; Zaher, M.R.; Elnomrosy, S.M.; Shemies, O.A.; Hussein, H.A.; Ahmed, E.S.; Ali, M.H.; Ateay, M.; Abdel-Hakim, M.A. Molecular Detection and Phylogenetic analysis of Newly Emerging Foot-and-mouth disease virus Type A, Lineage EURO-SA in Egypt in 2022. Virus Res. 2022, 323, 198960. [Google Scholar] [CrossRef] [PubMed]
  15. Grubman, M.J.; Baxt, B. Foot-and-mouth disease. Clin. Microbiol. Rev. 2004, 17, 465–493. [Google Scholar] [CrossRef] [Green Version]
  16. Belsham, G.J. Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure. Prog. Biophys. Mol. Biol. 1993, 60, 241–260. [Google Scholar] [CrossRef]
  17. Acharya, R.; Fry, E.; Stuart, D.; Fox, G.; Rowlands, D.; Brown, F. The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 1989, 337, 709–716. [Google Scholar] [CrossRef]
  18. Rweyemamu, M.; Roeder, P.; Mackay, D.; Sumption, K.; Brownlie, J.; Leforban, Y.; Valarcher, J.; Knowles, N.J.; Saraiva, V. Epidemiological patterns of foot-and-mouth disease worldwide. Transbound. Emerg. Dis. 2008, 55, 57–72. [Google Scholar] [CrossRef]
  19. Paton, D.J.; Sumption, K.J.; Charleston, B. Options for control of foot-and-mouth disease: Knowledge, capability and policy. Philos. Trans. R. Soc. B Biol. Sci. 2009, 364, 2657–2667. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  20. Refaei, O.H.M.; Yousif, A.A.A.; Hegazy, Y.M.; Soliman, S.M.; Salem, S.A.H.; Fayed, A.A.-A.M. Epidemiological investigation of foot-and-mouth disease outbreak in a vaccinated Egyptian dairy herd with analysis of associated risk factors. Jpn. J. Vet. Res. 2020, 68, 237–247. [Google Scholar]
  21. Hassan, A.M.; El-Mayet, F.S.; El-Habbaa, A.S.; Shahein, M.A.; El Zowalaty, M.E.; Hagag, N.M.; Sharawi, S.S.A. Molecular Characterization of Newly Emerging Foot-and-Mouth Disease Virus Serotype SAT 2 of Lib-12 Lineage Isolated from Egypt. Virus Res. 2022, 311, 198651. [Google Scholar] [CrossRef] [PubMed]
  22. Vosloo, W.; Bastos, A.D.S.; Sangare, O.; Hargreaves, S.K.; Thomson, G.R. Review of the status and control of foot and mouth disease in sub-Saharan Africa. Rev. Sci. Tech. Int. Des Épizooties 2002, 21, 437–445. [Google Scholar] [CrossRef]
  23. Knowles, N.J.; Wadsworth, J.; Reid, S.M.; Swabey, K.G.; El-Kholy, A.A.; Abd El-Rahman, A.O.; Soliman, H.M.; Ebert, K.; Ferris, N.P.; Hutchings, G.H. Foot-and-mouth disease virus serotype A in Egypt. Emerg. Infect. Dis. 2007, 13, 1593. [Google Scholar] [CrossRef]
  24. Kandeil, A.; El-Shesheny, R.; Kayali, G.; Moatasim, Y.; Bagato, O.; Darwish, M.; Gaffar, A.; Younes, A.; Farag, T.; Kutkat, M.A. Characterization of the recent outbreak of foot-and-mouth disease virus serotype SAT2 in Egypt. Arch. Virol. 2013, 158, 619–627. [Google Scholar] [CrossRef]
  25. Soltan, M.A.; Dohreig, R.M.A.; Abbas, H.; Ellawa, M.; Yousif, I.; Aly, A.E.; Wasfy, M.; El-Sayed, M.M. Emergence of foot and mouth disease virus, Lib-12 lineage of topotype VII, serotype SAT 2 in Egypt, 2018. Transbound. Emerg. Dis. 2019, 66, 1105–1106. [Google Scholar] [CrossRef] [PubMed]
  26. Al-Hosary, A.A.; Kandeil, A.; El-Taweel, A.N.; Nordengrahn, A.; Merza, M.; Badra, R.; Kayali, G.; Ali, M.A. Co-infection with different serotypes of FMDV in vaccinated cattle in Southern Egypt. Virus Genes 2019, 55, 304–313. [Google Scholar] [CrossRef]
  27. Jamal, S.M.; Ferrari, G.; Hussain, M.; Nawroz, A.H.; Aslami, A.A.; Khan, E.; Murvatulloev, S.; Ahmed, S.; Belsham, G.J. Detection and genetic characterization of foot-and-mouth disease viruses in samples from clinically healthy animals in endemic settings. Transbound. Emerg. Dis. 2012, 59, 429–440. [Google Scholar] [CrossRef]
  28. Cabezas, A.; Mapitse, N.; Tizzani, P.; Sanchez-Vazquez, M.; Stone, M.; Park, M. Analysis of suspensions and recoveries of official foot and mouth disease free status of WOAH Members between 1996 and 2020. Front. Vet. Sci. 2022, 9, 1013768. [Google Scholar] [CrossRef] [PubMed]
  29. Kitching, R.P.; Donaldson, A.I. Collecte et transport des prélèvements pour la recherche d’une infection vésiculeuse virale. Rev. Sci. Tech. 1987, 6, 251–283. [Google Scholar] [CrossRef]
  30. Reid, S.M.; Ferris, N.P.; Hutchings, G.H.; Samuel, A.R.; Knowles, N.J. Primary diagnosis of foot-and-mouth disease by reverse transcription polymerase chain reaction. J. Virol. Methods 2000, 89, 167–176. [Google Scholar] [CrossRef]
  31. Tamura, K.; Stecher, G.; Kumar, S. MEGA11: Molecular evolutionary genetics analysis version 11. Mol. Biol. Evol. 2021, 38, 3022–3027. [Google Scholar] [CrossRef] [PubMed]
  32. Tamura, K. Estimation of the number of nucleotide substitutions when there are strong transition-transversion and G+ C-content biases. Mol. Biol. Evol. 1992, 9, 678–687. [Google Scholar] [PubMed] [Green Version]
  33. Food and Agriculture Organization (FAO). Agency, U.S., Development, I. Livestock Production Systems Spotlight Cattle and Buffaloes and Poultry Sectors Livestock Production Systems Spotlight Cattle and Buffaloes, and Poultry Sectors in Egypt. Available online: http://www.fao.org/ag/againfo/programmes/en/ASL2050.html (accessed on 25 December 2022).
  34. Abdi, A.; Roushdy, S.; Beillard, M.J. Egypt Livestock and Products Annual 2019 Egyptian Beef Prices Stable, US Beef Imports Challenged; USDA Foreign Agricultural Service: Washington, DC, USA, 2020; pp. 1–12.
  35. Salem, S.A.; Bazid, A.-H.I.; Abo El-Hassan, D.J. Molecular and serological typing of foot-and-mouth disease virus serotypes currently circulating in Egypt. Iraqi J. Vet. Sci. 2021, 35, 581–588. [Google Scholar]
  36. Diab, E.; Bazid, A.-H.I.; Fawzy, M.; El-Ashmawy, W.R.; Fayed, A.A.; El-Sayed, M.M. Foot-and-mouth disease outbreaks in Egypt during 2013-2014: Molecular characterization of serotypes A, O, and SAT2. Vet. World 2019, 12, 190. [Google Scholar] [CrossRef] [Green Version]
  37. Mossad, G.; Rizk, S.A.; Abu-Elnaga, H.; Mohamed, A.A.; Abd El-kreem, A.; Farouk, E.M. Isolation and molecular characterization of foot and mouth disease SAT2 virus during outbreak 2012 in Egypt. J. Vet. Adv. 2013, 3, 60–68. [Google Scholar]
  38. El Damaty, H.M.; Fawzi, E.M.; Neamat-Allah, A.N.F.; Elsohaby, I.; Abdallah, A.; Farag, G.K.; El-Shazly, Y.A.; Mahmmod, Y.S. Characterization of foot and mouth disease virus serotype SAT-2 in swamp water buffaloes (Bubalus bubalis) under the Egyptian smallholder production system. Animals 2021, 11, 1697. [Google Scholar] [CrossRef] [PubMed]
  39. El-Khabaz, K.A.S.; Al-Hosary, A.A.T. Detection and identification of Foot and Mouth disease virus serotypes in Assiut governorate, Egypt. J. Adv. Vet. Anim. Res. 2017, 4, 32–38. [Google Scholar]
  40. Knowles, N.J.; Bachanek-Bankowska, K.; Wadsworth, J.; Mioulet, V.; Valdazo-González, B.; Eldaghayes, I.M.; Dayhum, A.S.; Kammon, A.M.; Sharif, M.A.; Waight, S. Outbreaks of foot-and-mouth disease in Libya and Saudi Arabia during 2013 due to an exotic O/ME-SA/Ind-2001 lineage virus. Transbound. Emerg. Dis. 2016, 63, e431–e435. [Google Scholar] [CrossRef] [Green Version]
  41. Carrillo, C.; Tulman, E.R.; Delhon, G.; Lu, Z.; Carreno, A.; Vagnozzi, A.; Kutish, G.F.; Rock, D.L. Comparative genomics of foot-and-mouth disease virus. J. Virol. 2005, 79, 6487–6504. [Google Scholar] [CrossRef] [Green Version]
  42. Freimanis, G.L.; Di Nardo, A.; Bankowska, K.; King, D.J.; Wadsworth, J.; Knowles, N.J.; King, D.P. Genomics and outbreaks: Foot and mouth disease. Rev. Sci. Tech. 2016, 35, 175–189. [Google Scholar] [CrossRef] [Green Version]
  43. Salam, H.M.; Mahmoud, A.A.; Khadr, A.M.; Salem, S.A.; Elshemey, T.M.; Abdelrahman, A.H.; Mahmoud, M.A. Isolation, sequencing and phylogenetic analysis of FMD strains during 2011–2012 outbreaks in Egypt. Int. J. Agric. Innov. Res. 2014, 3, 2319–2473. [Google Scholar]
  44. Soltan, M.A.; Negmaldin, A.H.; El-Diasty, M.M.; Mansour, S.M.G.; Elbadry, M.A.; Wilkes, R.P. Molecular characterization of circulating Foot and mouth disease virus (FMDV) serotype O topotype EA-3 and serotype A (African topotype) genotype IV in Egypt, 2016. Vet. Microbiol. 2017, 208, 89–93. [Google Scholar] [CrossRef]
  45. Di Nardo, A.; Knowles, N.J.; Paton, D.J. Combining livestock trade patterns with phylogenetics to help understand the spread of foot and mouth disease in sub-Saharan Africa, the Middle East and Southeast Asia. Rev. Sci. Tech. 2011, 30, 63. [Google Scholar] [CrossRef] [PubMed]
  46. Malirat, V.; Bergmann, I.E.; de Mendonça Campos, R.; Conde, F.; Quiroga, J.L.; Villamil, M.; Salgado, G.; Ortiz, S. Molecular epidemiology of foot-and-mouth disease virus type A in South America. Vet. Microbiol. 2012, 158, 82–94. [Google Scholar] [CrossRef]
  47. Machín Pire, C.C.; Medina Gutierrez, G.M.; Perez, C.G.; López Ramón, J.A. Genetic diversity of Foot-and-Mouth Disease Virus serotype A in Venezuela (2001–2013). Zootec. Trop. 2016, 34, 191–200. [Google Scholar]
  48. Naranjo, J.; Cosivi, O. Elimination of foot-and-mouth disease in South America: Lessons and challenges. Philos. Trans. R. Soc. B Biol. Sci. 2013, 368, 20120381. [Google Scholar] [CrossRef]
  49. Sundberg, P. Emerging viral diseases and health risks for global markets. Rev. Acad. Cienc. Anim. 2019, 17, 39–42. [Google Scholar]
  50. Abdul-Hamid, N.F.; Hussein, N.M.; Wadsworth, J.; Radford, A.D.; Knowles, N.J.; King, D.P. Phylogeography of foot-and-mouth disease virus types O and A in Malaysia and surrounding countries. Infect. Genet. Evol. 2011, 11, 320–328. [Google Scholar] [CrossRef] [PubMed]
  51. Fry, E.E.; Newman, J.W.I.; Curry, S.; Najjam, S.; Jackson, T.; Blakemore, W.; Lea, S.M.; Miller, L.; Burman, A.; King, A.M.Q. Structure of Foot-and-mouth disease virus serotype A1061 alone and complexed with oligosaccharide receptor: Receptor conservation in the face of antigenic variation. J. Gen. Virol. 2005, 86, 1909–1920. [Google Scholar] [CrossRef]
  52. Lawrence, P.; Pacheco, J.M.; Uddowla, S.; Hollister, J.; Kotecha, A.; Fry, E.; Rieder, E. Foot-and-mouth disease virus (FMDV) with a stable FLAG epitope in the VP1 GH loop as a new tool for studying FMDV pathogenesis. Virology 2013, 436, 150–161. [Google Scholar] [CrossRef] [Green Version]
  53. Mittal, M.; Tosh, C.; Hemadri, D.; Sanyal, A.; Bandyopadhyay, S.K. Phylogeny, genome evolution, and antigenic variability among endemic foot-and-mouth disease virus type A isolates from India. Arch. Virol. 2005, 150, 911–928. [Google Scholar] [CrossRef] [PubMed]
  54. Mahmoud, E.A.; Neamat-allah, A.N.F. Hemato-Biochemical Studies on Egyptian Buffaloes and Calves Naturally Infected with Foot and Mouth Disease Virus Serotype SAT2. Bull. Univ. Agric. Sci. Vet. Med. Cluj-Napoca. Vet. Med. 2016, 73, 230–237. [Google Scholar]
  55. Abd El Moneim, A.A.; Hafez, M.H.; Ahmed, B.; Hasanin, S.A.; Algabri, N.; Sheire, H.A.; Dhamar, Y. Pathological and Molecular Investigations on Foot and Mouth Virus Outbreaks Among Cattle Herds in Dakahlia Governorate, Egypt. Zagazig Vet. J. 2016, 44, 128–137. [Google Scholar]
  56. Pega, J.; Bucafusco, D.; Di Giacomo, S.; Schammas, J.M.; Malacari, D.; Capozzo, A.V.; Arzt, J.; Pérez-Beascoechea, C.; Maradei, E.; Rodríguez, L.L. Early adaptive immune responses in the respiratory tract of foot-and-mouth disease virus-infected cattle. J. Virol. 2013, 87, 2489–2495. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  57. Stenfeldt, C.; Eschbaumer, M.; Rekant, S.I.; Pacheco, J.M.; Smoliga, G.R.; Hartwig, E.J.; Rodriguez, L.L.; Arzt, J. The foot-and-mouth disease carrier state divergence in cattle. J. Virol. 2016, 90, 6344–6364. [Google Scholar] [CrossRef] [Green Version]
Figure 1. Calves showed clinical signs of foot-and-mouth disease: vesicles, erosions, and ulcers on the tongue and gums, and salivation in (A) buffalo calf that showed a violet discoloration of the oral cavity due to the topical use of antiseptics, (B) cattle calf. (C) Buffalo calves showed inappetence to anorexia, dullness, and isolation from the herd. (D) Cattle calves showed mild anorexia and dullness.
Figure 1. Calves showed clinical signs of foot-and-mouth disease: vesicles, erosions, and ulcers on the tongue and gums, and salivation in (A) buffalo calf that showed a violet discoloration of the oral cavity due to the topical use of antiseptics, (B) cattle calf. (C) Buffalo calves showed inappetence to anorexia, dullness, and isolation from the herd. (D) Cattle calves showed mild anorexia and dullness.
Vetsci 10 00488 g001
Figure 2. Maximum likelihood (ML) phylogenetic tree based on the 600 base pairs nucleotide of the VP1 region of foot-and-mouth disease virus genome corresponding to nucleotide positions 2364-2964 in the whole genome sequence of KP940474/A/Egypt/2014 reference strain. It included two isolates that were marked with black squares (accession No. OP823161 and OP823163) out of the 20 identical sequences in the current study, together with 30 isolates from GenBank (NCBI). These 30 isolates represented the different serotype A topotypes (Europe–South America, Asia, and Africa) that occurred worldwide, and each isolate was labeled with its accession number and the country of origin. Evolutionary analysis was conducted using MEGA11 software. One thousand replications were performed to calculate the bootstrap values indicated on the tree. The bar in the lower-left corner of the figure denotes distance.
Figure 2. Maximum likelihood (ML) phylogenetic tree based on the 600 base pairs nucleotide of the VP1 region of foot-and-mouth disease virus genome corresponding to nucleotide positions 2364-2964 in the whole genome sequence of KP940474/A/Egypt/2014 reference strain. It included two isolates that were marked with black squares (accession No. OP823161 and OP823163) out of the 20 identical sequences in the current study, together with 30 isolates from GenBank (NCBI). These 30 isolates represented the different serotype A topotypes (Europe–South America, Asia, and Africa) that occurred worldwide, and each isolate was labeled with its accession number and the country of origin. Evolutionary analysis was conducted using MEGA11 software. One thousand replications were performed to calculate the bootstrap values indicated on the tree. The bar in the lower-left corner of the figure denotes distance.
Vetsci 10 00488 g002
Figure 3. Comparison of amino acid sequences of the immunogenic (G-H loop) region of VP1 in the obtained isolate (accession No. OP823161) with the strain recently identified in Egypt (Reference), and isolates from Egypt, Venezuela, and others included in the Egyptian FMD vaccines. Each isolate was labeled with its accession number and the country of origin (Left panel). Alignment of amino acid sequences, located at 136–155 positions of G-H loop corresponding to amino acids positions 141–160 of whole VP1 sequence; the dots indicate the identity of the amino acids (Middle panel). The number of amino acid substitutions was counted and written in front of each isolate (Right panel).
Figure 3. Comparison of amino acid sequences of the immunogenic (G-H loop) region of VP1 in the obtained isolate (accession No. OP823161) with the strain recently identified in Egypt (Reference), and isolates from Egypt, Venezuela, and others included in the Egyptian FMD vaccines. Each isolate was labeled with its accession number and the country of origin (Left panel). Alignment of amino acid sequences, located at 136–155 positions of G-H loop corresponding to amino acids positions 141–160 of whole VP1 sequence; the dots indicate the identity of the amino acids (Middle panel). The number of amino acid substitutions was counted and written in front of each isolate (Right panel).
Vetsci 10 00488 g003
Table 1. Number and distribution of samples from cattle and buffalo calves in Beheira province.
Table 1. Number and distribution of samples from cattle and buffalo calves in Beheira province.
LocationDamanhourAbu HommusAbu AlmatamerKafr
El-Dawar
Total
Population
No. of tested farms 121 *15
No. of samples per farm 488420
No. of cattle/buffalo samples2:24:42:22:210:10
History of FMD vaccinationNoNoNoYes1
Study of clinical and epidemiological parameters in farms NoNoYesNo2
* Farm was comprising 70 calves that were investigated for epidemiological and clinical parameters.
Table 2. Nucleotides and deduced amino acids’ identity of the obtained isolates (OP823161–OP823164) compared to worldwide sequences of serotype A lineage.
Table 2. Nucleotides and deduced amino acids’ identity of the obtained isolates (OP823161–OP823164) compared to worldwide sequences of serotype A lineage.
TopotypeAccession No.CountryNucleotides Identity (%) *Amino Acids Identity (%) **OriginIsolation Year
Euro-SA
OP823161Egypt Study isolate -Buffalo2022
OP823164EgyptStudy isolate -Cattle2022
OP093730Egypt100100Cattle2022
OP131711Egypt100100Cattle2022
KX150534Venezuela87.587.6Bovine2011
KX150532Venezuela86.986.9Bovine2006
KX150522Venezuela86.489.5Bovine2006
MT412356Brazil78.982.4Bovine2020
AY593773Peru73.285.7N. host ***1969
AY593774Spain72.780.1N. host ***1969
AY593769Argentina72.279.5N. host ***1959
AY593777Germany72.180.1N. host ***1969
AY593751Netherland70.780.1N. host ***1942
AY593771Colombia70.282.9N. host ***1967
AY593792Italy7080.1N. host ***1962
Asia
OM455481Pakistan66.877.3Buffalo2012
MT981292Iran6678.8Cattle2005
HM854023India65.378.8Cattle1999
MT340197Vietnam64.678.5Cattle2017
Africa
AY593761Kenya70.379.5N. host ***1964
MH053305Egypt67.580.2Cattle1972
MG725874Nigeria6575Cattle2015
MH053307Zambia64.677.3Cattle1990
MT863268Egypt63.274.2Buffalo2016
MT602078Ethiopia62.376.5Cattle2019
MW413351Egypt62.273.4Cattle2020
MT602079Sudan61.473.4Cattle2018
MW413350Egypt59.870.1Cattle2020
MG913340Algeria59.772.6Cattle2017
KP940474Egypt58.672.6Cattle2014
KY825726Egypt58.672.6N. host ***2011
KC440881Egypt58.672.6Bovine2011
* Partial nucleotide sequence of 600 bp of 1D gene. ** A number of 200 deduced amino acids. *** Isolates obtained from their natural hosts and adapted to guinea pigs or cell lines.
Table 3. Differences in epidemiological parameters and clinical findings of FMD-infected buffalo and cattle calves in a mixed-rearing Egyptian farm.
Table 3. Differences in epidemiological parameters and clinical findings of FMD-infected buffalo and cattle calves in a mixed-rearing Egyptian farm.
Epidemiological & Clinical FindingsInfected Buffalo Calves (%; 95% CI)Infected Cattle Calves (%; 95% CI)p-Value *Total (%)
No. of tested calves3535 70
Epidemiological parameters
Morbidity rate 35/35 (100.0)35/35 (100.0) 70/70 (100.0)
Mortality rate9/35 (25.7; 13–43)3/35 (8.6; 2–24)0.1112/70 (17.1)
Case-fatality rate 9/35 (25.7; 13–43)3/35 (8.6; 2–24)0.1112/70 (17.1)
Course of disease in fatal cases 2–3 days6–8 days 2–8 days
Course of disease in recovered cases 2–3 weeks 2–4 weeks 2–4 weeks
Clinical findings
Inappetence to anorexia 35/35 (100.0)27/35 (77.1)0.00462/70 (88.6)
Dull and depressed 30/35 (85.7; 69–95)22/35 (62.9; 45–78)0.05452/70 (74.3)
Recumbent or prefer recumbence25/35 (71.4; 53–85)9/35 (25.7; 13–43)0.000234/70 (48.6)
Vesicles on mouth and foot 23/35 (65.7; 51–84)31/35 (88.6; 72–96)0.0454/70 (77.1)
Salivation 14/35 (40.0; 24–58)25/35 (71.4; 53–85)0.0139/70 (55.7)
Lameness 9/35 (25.7; 13–43)12/35 (34.3; 20–52)0.621/70 (30.0)
Clinical parameters
Body temperature
Rectal temperature range (°C) b36.2–41.5 a36.5–41.7 a -
Abnormal temperature35/35 (100.0)35/35 (100.0) 70/70 (100.0)
Hyperthermia23/35 (65.7; 51–84)31/35 (88.6; 72–96)0.0454/70 (77.1)
Hypothermia12/35 (34.3; 20–52)4/35 (11.4; 4–28)0.0416/70 (22.9)
Heart auscultation
Heart rate range (Beat/minute) c38–160 a39–155 a -
Tachycardia 23/35 (65.7; 51–84)31/35 (88.6; 72–96)0.0454/70 (77.1)
Bradycardia 12/35 (34.3; 20–52)4/35 (11.4; 4–28)0.0416/70 (22.9)
Cardiac arrhythmia 14/35 (40.0; 24–58)6/35 (17.1; 7–34)0.0620/70 (28.6)
Respiratory parameters
Respiratory rate (Resp. cycles/minute) d11–62 a12–66 a -
Abnormal lung sound16/35 (45.7; 29–63)28/35 (80.0; 63–91)0.00544/70 (62.9)
Nasal discharge 8/35 (22.9; 11–41)20/35 (57.1; 40–73)0.00628/70 (40.0)
Chronic signs in recovered calves
Respiratory signs 2/26 (7.7; 1–26)4/32 (12.5; 4–30)0.66/70 (8.6)
Diarrhea 2/26 (7.7, 1–26)00.192/70 (2.9)
a Rectal temperature, heart rate, and respiratory rate ranges of all 35 diseased calves. b Normal temperature of buffalo calves is 38–38.8 °C and cattle calves is 37.9–38.7 °C. c Normal heart rate of buffalo calves is 90–110 and cattle calves is 95–112 beats/min. d Normal respiratory rate of buffalo calves is 20–25 and cattle calves is 19–28 beats/min. * p-value of <0.05 was considered statistically significant.
Table 4. Summary of the effect of the identified FMD, serotype A, Euro–SA on buffalo and cattle calves during an outbreak in the Beheira province.
Table 4. Summary of the effect of the identified FMD, serotype A, Euro–SA on buffalo and cattle calves during an outbreak in the Beheira province.
AnimalBuffalo CalvesCattle Calves
Item
Causative agentFMD, Serotype A, Euro-SAFMD, Serotype A, Euro-SA
Cytopathic effectObserved on 1st dayObserved on 1st day
VP1 gene similarityIdentical to OP093730Identical to OP093730
MorbidityHighHigh
Acute clinical signsMore severeSevere
Chronic signsYesNo
FatalityRapid and highSlow and less
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Metwally, S.; Bkear, N.; Badr, Y.; Elshafey, B.; Alhag, S.K.; Al-Shuraym, L.A.; Batiha, G.; Fakhry, B.; Hamada, R. A Newly Emerging Serotype A Strain in Foot-and-Mouth Disease Virus with Higher Severity and Mortality in Buffalo than in Cattle Calves in North Egypt. Vet. Sci. 2023, 10, 488. https://doi.org/10.3390/vetsci10080488

AMA Style

Metwally S, Bkear N, Badr Y, Elshafey B, Alhag SK, Al-Shuraym LA, Batiha G, Fakhry B, Hamada R. A Newly Emerging Serotype A Strain in Foot-and-Mouth Disease Virus with Higher Severity and Mortality in Buffalo than in Cattle Calves in North Egypt. Veterinary Sciences. 2023; 10(8):488. https://doi.org/10.3390/vetsci10080488

Chicago/Turabian Style

Metwally, Samy, Nabil Bkear, Yassien Badr, Besheer Elshafey, Sadeq K. Alhag, Laila A. Al-Shuraym, Gaber Batiha, Bassant Fakhry, and Rania Hamada. 2023. "A Newly Emerging Serotype A Strain in Foot-and-Mouth Disease Virus with Higher Severity and Mortality in Buffalo than in Cattle Calves in North Egypt" Veterinary Sciences 10, no. 8: 488. https://doi.org/10.3390/vetsci10080488

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop